DK0482084T3 - (1,2N)- og (3,2N)-carbocyklisk-2-amino-tetralin-derivater. - Google Patents
(1,2N)- og (3,2N)-carbocyklisk-2-amino-tetralin-derivater.Info
- Publication number
- DK0482084T3 DK0482084T3 DK90911443.1T DK90911443T DK0482084T3 DK 0482084 T3 DK0482084 T3 DK 0482084T3 DK 90911443 T DK90911443 T DK 90911443T DK 0482084 T3 DK0482084 T3 DK 0482084T3
- Authority
- DK
- Denmark
- Prior art keywords
- carbocyclic
- amino
- tetralin derivatives
- useful
- tetralin
- Prior art date
Links
- -1 carbocyclic 2-amino-tetralin derivatives Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/08—Aza-anthracenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37952689A | 1989-07-13 | 1989-07-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0482084T3 true DK0482084T3 (da) | 1997-11-03 |
Family
ID=23497619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90911443.1T DK0482084T3 (da) | 1989-07-13 | 1990-06-27 | (1,2N)- og (3,2N)-carbocyklisk-2-amino-tetralin-derivater. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5491236A (da) |
| EP (1) | EP0482084B1 (da) |
| JP (1) | JP3005287B2 (da) |
| KR (1) | KR0151699B1 (da) |
| AT (1) | ATE152708T1 (da) |
| AU (1) | AU648032B2 (da) |
| CA (1) | CA2057912C (da) |
| DE (1) | DE69030665T2 (da) |
| DK (1) | DK0482084T3 (da) |
| ES (1) | ES2100886T3 (da) |
| WO (1) | WO1991000856A2 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486611A (en) * | 1989-07-13 | 1996-01-23 | The Upjohn Company | Carboxamido-(1,2N)-carbocyclic-2-aminotetralin derivatives |
| ATE178893T1 (de) * | 1990-01-11 | 1999-04-15 | Upjohn Co | 6,7,8,9-tetrahydro-3h-benz(e)indolheterocyclen mit wirkung auf das zentrale nervensystem |
| JP3155276B2 (ja) * | 1991-05-20 | 2001-04-09 | ファルマシア・アンド・アップジョン・カンパニー | カルボキサミド−（１，２ｎ）−カルボサイクリック−２−アミノテトラリン誘導体 |
| AU2153592A (en) * | 1991-05-20 | 1993-01-08 | Upjohn Company, The | Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives |
| TW239127B (da) * | 1991-12-20 | 1995-01-21 | Hoffmann La Roche | |
| NZ314570A (en) * | 1993-06-10 | 2000-11-24 | Lilly Co Eli | Treatment of emesis using tetrahydrobenz[cd]indole-6-carboxamides |
| GB9612153D0 (en) * | 1996-06-11 | 1996-08-14 | Smithkline Beecham Plc | Compounds |
| DE19834714A1 (de) * | 1998-07-31 | 2000-02-03 | Boehringer Ingelheim Pharma | Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
| GB0517292D0 (en) * | 2005-08-24 | 2005-10-05 | Univ Dundee | Cell migration modulating compounds |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1555553A (da) * | 1967-07-05 | 1969-01-31 | ||
| US3839338A (en) * | 1968-05-09 | 1974-10-01 | W Michne | 1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO{8 g{9 QUINOLINES |
| GB1277789A (en) | 1969-09-08 | 1972-06-14 | Logeais Labor Jacques | Improvements in or relating to new polycyclic pyrrole derivatives |
| US3898235A (en) | 1970-12-02 | 1975-08-05 | Sterling Drug Inc | Octahydrobenzo {8 g{9 {0 quinolines and hexahydroindeno {8 1,2,b{9 {0 pyridines |
| JPS4930836B1 (da) * | 1971-07-22 | 1974-08-16 | ||
| US4234731A (en) * | 1979-01-05 | 1980-11-18 | Bristol-Myers Company | 9-Oxobenzomorphan process |
| US4341786A (en) * | 1981-03-02 | 1982-07-27 | Smithkline Corporation | Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds |
| US4618683A (en) * | 1982-06-01 | 1986-10-21 | Abbott Laboratories | Tetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the treatment of hypertension and as sedatives |
| PH22782A (en) * | 1983-02-01 | 1988-12-12 | Sandoz Ltd | Novel pharmaceutical active 1,2,3,4,4a,5,10,10a octahydrobenzo(g)quinoline derivatives |
| SE8302361D0 (sv) * | 1983-04-27 | 1983-04-27 | Astra Laekemedel Ab | New tricyclic amines |
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| CA2011640A1 (en) * | 1989-03-20 | 1990-09-20 | F. Hoffmann-La Roche Ag | Quinoline derivatives |
| US5244888A (en) * | 1989-11-17 | 1993-09-14 | Abbott Laboratories | 5-HT selective agents |
| US5180733A (en) * | 1990-03-30 | 1993-01-19 | Abbott Laboratories | Biogenic amine uptake inhibitors |
| US5248677A (en) * | 1990-03-30 | 1993-09-28 | Abbott Laboratories | Biogentic amine uptake inhibitors |
| TW239127B (da) * | 1991-12-20 | 1995-01-21 | Hoffmann La Roche |
-
1990
- 1990-06-27 AU AU61453/90A patent/AU648032B2/en not_active Ceased
- 1990-06-27 EP EP90911443A patent/EP0482084B1/en not_active Expired - Lifetime
- 1990-06-27 KR KR1019920700056A patent/KR0151699B1/ko not_active Expired - Fee Related
- 1990-06-27 ES ES90911443T patent/ES2100886T3/es not_active Expired - Lifetime
- 1990-06-27 WO PCT/US1990/003551 patent/WO1991000856A2/en not_active Ceased
- 1990-06-27 DE DE69030665T patent/DE69030665T2/de not_active Expired - Fee Related
- 1990-06-27 AT AT90911443T patent/ATE152708T1/de not_active IP Right Cessation
- 1990-06-27 DK DK90911443.1T patent/DK0482084T3/da active
- 1990-06-27 CA CA002057912A patent/CA2057912C/en not_active Expired - Fee Related
- 1990-06-27 JP JP2510978A patent/JP3005287B2/ja not_active Expired - Fee Related
-
1991
- 1991-12-04 US US07/803,287 patent/US5491236A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2057912A1 (en) | 1991-01-14 |
| KR0151699B1 (ko) | 1998-10-15 |
| WO1991000856A2 (en) | 1991-01-24 |
| DE69030665D1 (de) | 1997-06-12 |
| EP0482084A1 (en) | 1992-04-29 |
| CA2057912C (en) | 1996-10-29 |
| KR927003529A (ko) | 1992-12-18 |
| ES2100886T3 (es) | 1997-07-01 |
| AU648032B2 (en) | 1994-04-14 |
| WO1991000856A3 (en) | 1991-03-21 |
| JPH04507408A (ja) | 1992-12-24 |
| US5491236A (en) | 1996-02-13 |
| ATE152708T1 (de) | 1997-05-15 |
| DE69030665T2 (de) | 1997-10-02 |
| EP0482084B1 (en) | 1997-05-07 |
| JP3005287B2 (ja) | 2000-01-31 |
| AU6145390A (en) | 1991-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU554206B2 (en) | 1-alkyl-2-aminotetralin derivatives | |
| DE69331103D1 (de) | Substituierte benzylamin-stickstoff enthaltende nichtaromatische heterocyclen | |
| FI941378A0 (fi) | Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus | |
| FI935675A0 (fi) | Pyrazolopyrimidiner | |
| NO914714L (no) | Terapeutisk anvendbare 2-aminotetralinderivater | |
| CA2134964A1 (en) | Bridged Aza-Bicyclic Derivatives as Substance P Antagonists | |
| DE69615682D1 (de) | N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide | |
| NO870199D0 (no) | Alalogifremgangsmaate for fremstilling av nye, terapeutisk virksomme dihydrobenzofuran- og chroman-carboxamidderivater. | |
| DK0765320T3 (da) | Benzimidazolonderivater med central dopaminerg aktivitet | |
| ATE152708T1 (de) | (1,2n) und (3,2n)-karbozyklische-2-amino- tetralinderivate | |
| RU94039284A (ru) | Производные пиперазина, способ их получения, фармкомпозиция и ее использование | |
| SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
| ES8705464A1 (es) | Un procedimiento para la preparacion de nuevos peptidos. | |
| TNSN86165A1 (fr) | Nouveaux ortho-anisamides, leur procede d'obtention et leurs applications therapeutiques | |
| FI943875A0 (fi) | 2,3,4,5-Tetrahydro-1H-3-bentsatsepiinejä ja niiden farmaseuttisesti hyväksyttäviä happoadditiosuoloja | |
| ATE52776T1 (de) | 1-phenyl-3-benzazepine. | |
| BR9406996A (pt) | Enanciômero processo para preparar o mesmo processo para ciclizar um composto e composto intermediário | |
| WO1992021654A3 (en) | Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives | |
| SE8305362D0 (sv) | Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds |